review·The Lancet·Mar 1, 2012Closed access

Rheumatic heart disease

ÉMÉloi MarijonCorresponding authorMMMariana MirabelDSDavid S. CelermajerXJXavier Jouven

Inserm · Université Paris Cité · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

848
total citations
FWCI
52.06
Percentile
100%
References
427
Citations per year

Authors

4
  • ÉM
    Éloi MarijonCorresponding

    Inserm, Université Paris Cité, Délégation Paris 5, Hôpital Européen Georges-Pompidou, Paris Cardiovascular Research Center

  • MM
    Mariana Mirabel

    University College London, Paris Cardiovascular Research Center, Délégation Paris 5, Université Paris Cité, Inserm

  • DS
    David S. Celermajer

    University of Sydney

  • XJ
    Xavier Jouven

    Paris Cardiovascular Research Center, Délégation Paris 5, Université Paris Cité, Hôpital Européen Georges-Pompidou, Inserm

Topics & keywords

Topics
  • Primary topicStreptococcal Infections and Treatments100%
  • Infective Endocarditis Diagnosis and Management100%
  • Antimicrobial Resistance in Staphylococcus98%
Keywords
  • Medicine
  • Rheumatic fever
  • Heart disease
  • Intensive care medicine
  • Disease
  • Acute rheumatic fever
  • Heart failure
  • Disease management
No related works found for this paper.

Funding

  • NH
    National Heart Foundation of Australia